225 related articles for article (PubMed ID: 10999827)
1. Treatment of familial hyperaldosteronism type I: only partial suppression of adrenocorticotropin required to correct hypertension.
Stowasser M; Bachmann AW; Huggard PR; Rossetti TR; Gordon RD
J Clin Endocrinol Metab; 2000 Sep; 85(9):3313-8. PubMed ID: 10999827
[TBL] [Abstract][Full Text] [Related]
2. Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance.
Stowasser M; Bachmann AW; Huggard PR; Rossetti TR; Gordon RD
J Clin Endocrinol Metab; 2000 Jun; 85(6):2160-6. PubMed ID: 10852446
[TBL] [Abstract][Full Text] [Related]
3. Biochemical evidence of aldosterone overproduction and abnormal regulation in normotensive individuals with familial hyperaldosteronism type I.
Stowasser M; Huggard PR; Rossetti TR; Bachmann AW; Gordon RD
J Clin Endocrinol Metab; 1999 Nov; 84(11):4031-6. PubMed ID: 10566645
[TBL] [Abstract][Full Text] [Related]
4. In familial hyperaldosteronism type I, hybrid gene-induced aldosterone production dominates that induced by wild-type genes.
Stowasser M; Gartside MG; Taylor WL; Tunny TJ; Gordon RD
J Clin Endocrinol Metab; 1997 Nov; 82(11):3670-6. PubMed ID: 9360524
[TBL] [Abstract][Full Text] [Related]
5. Primary aldosteronism: learning from the study of familial varieties.
Stowasser M; Gordon RD
J Hypertens; 2000 Sep; 18(9):1165-76. PubMed ID: 10994747
[TBL] [Abstract][Full Text] [Related]
6. Evidence for persistent dysfunction of wild-type aldosterone synthase gene in glucocorticoid-treated familial hyperaldosteronism type I.
Stowasser M; Taylor WL; Gartside MG; Tunny TJ; Gordon RD
J Hypertens; 1997 Dec; 15(12 Pt 2):1729-33. PubMed ID: 9488230
[TBL] [Abstract][Full Text] [Related]
7. Clinical, biochemical and genetic approaches to the detection of familial hyperaldosteronism type I.
Stowasser M; Bachmann AW; Jonsson JR; Tunny TJ; Klemm SA; Gordon RD
J Hypertens; 1995 Dec; 13(12 Pt 2):1610-3. PubMed ID: 8903619
[TBL] [Abstract][Full Text] [Related]
8. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
9. Long term evolution of glucocorticoid-suppressible hyperaldosteronism.
Stockigt JR; Scoggins BA
J Clin Endocrinol Metab; 1987 Jan; 64(1):22-6. PubMed ID: 3536983
[TBL] [Abstract][Full Text] [Related]
10. Overproduction of sodium-retaining steroids by the zona glomerulosa is adrenocorticotropin-dependent and mediates hypertension in dexamethasone-suppressible aldosteronism.
Gill JR; Bartter FC
J Clin Endocrinol Metab; 1981 Aug; 53(2):331-7. PubMed ID: 6265487
[TBL] [Abstract][Full Text] [Related]
11. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.
Fardella CE; Mosso L; Gómez-Sánchez C; Cortés P; Soto J; Gómez L; Pinto M; Huete A; Oestreicher E; Foradori A; Montero J
J Clin Endocrinol Metab; 2000 May; 85(5):1863-7. PubMed ID: 10843166
[TBL] [Abstract][Full Text] [Related]
12. Urinary free cortisol is not a biochemical marker of hypertension.
Krall P; Carvajal C; Ortiz E; Muñoz C; Garrido JL; Mosso L; Fardella C
Am J Hypertens; 2007 Apr; 20(4):459-65. PubMed ID: 17386356
[TBL] [Abstract][Full Text] [Related]
13. The role of ACTH in the episodic release of aldosterone in patients with idiopathic adrenal hyperplasia, hypertension, and hyperaldosteronism.
Kem DC; Weinberger MH; Gomez-Sanchez C; Higgins JR; Kramer NJ
J Lab Clin Med; 1976 Aug; 88(2):261-70. PubMed ID: 182890
[TBL] [Abstract][Full Text] [Related]
14. Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism.
Fallo F; Pilon C; Williams TA; Sonino N; Morra Di Cella S; Veglio F; De Iasio R; Montanari P; Mulatero P
J Hum Hypertens; 2004 Jan; 18(1):47-51. PubMed ID: 14688810
[TBL] [Abstract][Full Text] [Related]
15. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
[TBL] [Abstract][Full Text] [Related]
16. Production of 18-oxo-cortisol in subtypes of primary aldosteronism.
Stowasser M; Bachmann AW; Tunny TJ; Gordon RD
Clin Exp Pharmacol Physiol; 1996; 23(6-7):591-3. PubMed ID: 8800594
[TBL] [Abstract][Full Text] [Related]
17. [Possible pathogenetic role of 11 beta-hydroxysteroid dehydrogenase type 1 (11betaHSD1) gene polymorphisms in arterial hypertension].
Morales MA; Carvajal CA; Ortiz E; Mosso LM; Artigas RA; Owen GI; Fardella CE
Rev Med Chil; 2008 Jun; 136(6):701-10. PubMed ID: 18769825
[TBL] [Abstract][Full Text] [Related]
18. Primary hyperaldosteronism without suppressed renin due to secondary hypertensive kidney damage.
Oelkers W; Diederich S; Bähr V
J Clin Endocrinol Metab; 2000 Sep; 85(9):3266-70. PubMed ID: 10999820
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and therapy surveillance in Addison's disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone.
Oelkers W; Diederich S; Bähr V
J Clin Endocrinol Metab; 1992 Jul; 75(1):259-64. PubMed ID: 1320051
[TBL] [Abstract][Full Text] [Related]
20. Familial hyperaldosteronism type II: description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene.
Torpy DJ; Gordon RD; Lin JP; Huggard PR; Taymans SE; Stowasser M; Chrousos GP; Stratakis CA
J Clin Endocrinol Metab; 1998 Sep; 83(9):3214-8. PubMed ID: 9745430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
